New Delhi: Shares of Dr Reddy’s Laboratories settled five per cent lower on Monday after the company said the US health regulator issued three observations for the company’s Hyderabad-based research facility.
The stock of the company plunged 5.04 per cent to close at Rs5,472.90 apiece on the BSE. On the NSE, Dr Reddy’s Laboratories scrip declined 5 per cent to end at Rs5,475.70 apiece. During the day, shares of the company touched a low of Rs5,371.75 on the BSE and Rs5,370 apiece on the NSE. On the volume front, 18.98 lakh equity shares were traded on the NSE, while 40,000 shares changed hands on the BSE. Meanwhile, the 30-share BSE Sensex jumped 102.93 points, or 0.15 per cent, higher to close at 69,928.53, while NSE Nifty rose 27.70 points to settle at 20,997.10.
